- Home
- MED vs AMRN Comparison
MED vs AMRN Comparison
Compare MED & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- AMRN
- Stock Information
- Founded
- MED 1980
- AMRN 1989
- Country
- MED United States
- AMRN Ireland
- Employees
- MED N/A
- AMRN N/A
- Industry
- MED Packaged Foods
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- AMRN Health Care
- Exchange
- MED Nasdaq
- AMRN Nasdaq
- Market Cap
- MED 187.3M
- AMRN 189.2M
- IPO Year
- MED N/A
- AMRN 1993
- Fundamental
- Price
- MED $15.48
- AMRN $0.55
- Analyst Decision
- MED Hold
- AMRN Buy
- Analyst Count
- MED 1
- AMRN 1
- Target Price
- MED $17.00
- AMRN N/A
- AVG Volume (30 Days)
- MED 204.6K
- AMRN 1.1M
- Earning Date
- MED 02-18-2025
- AMRN 02-27-2025
- Dividend Yield
- MED N/A
- AMRN N/A
- EPS Growth
- MED N/A
- AMRN N/A
- EPS
- MED 0.67
- AMRN N/A
- Revenue
- MED $674,475,000.00
- AMRN $241,021,000.00
- Revenue This Year
- MED N/A
- AMRN N/A
- Revenue Next Year
- MED N/A
- AMRN N/A
- P/E Ratio
- MED $23.25
- AMRN N/A
- Revenue Growth
- MED N/A
- AMRN N/A
- 52 Week Low
- MED $14.88
- AMRN $0.43
- 52 Week High
- MED $56.52
- AMRN $1.36
- Technical
- Relative Strength Index (RSI)
- MED 36.38
- AMRN 50.48
- Support Level
- MED $15.67
- AMRN $0.55
- Resistance Level
- MED $16.30
- AMRN $0.61
- Average True Range (ATR)
- MED 0.55
- AMRN 0.04
- MACD
- MED 0.09
- AMRN -0.00
- Stochastic Oscillator
- MED 25.16
- AMRN 26.56
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.